Sagimet Biosciences Inc-A

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.73

-0.06 (-0.77%)

As of Jun 30, 10:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 89%

Hold 2 11%

Sell 0 0%

Price Target

Analyst Price Target -61.2% upside

Low Target $2.20

Average Target $3.00

High Target $3.42

Current Price $7.73

Current
$7.73

Target
$3.00

$2.20 $3.00 avg $3.42

Scenario Analysis

Bear Case

$2.20

-71.5%

Low target

Base Case

$3.00

-61.2%

Avg target

Bull Case

$3.42

+-55.8%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$11.41

-32.3% from high

52-Week Low

$4.50

+71.8% from low

Target vs 52W High

$3.00

-73.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%